Publications

5491 Results

PROSPER: Phase III RandOmized Study Comparing PERioperative Nivolumab versus Observation in Patients with Renal Cell Carcinoma (RCC) Undergoing Nephrectomy (ECOG-ACRIN EA8143)

Authors
M Allaf;S Kim;V Master;D McDermott;C Drake;S Signoretti;D Cella;R Gupta;S Cole;B Shuch;P Lara;A Kapoor;D Heng;B Leibovich;M Michaelson;T Choueiri;M Jewett;D Maskens;L Harshman;M Carducci;N Haas
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS4596) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8143

EA8185: Phase 2 Study of Bladder-SparIng ChemoradiatioN (chemoRT) with Durvalumab in Clinical Stage III, Node PosItive URothElial Carcinoma (INSPIRE), an ECOG-ACRIN & NRG Collaboration

Authors
M Joshi;S Kim;A Solanki;D Miyamoto;D Degraff;J Zou;J Meeks;T Mitin;S Collins;E Trabulsi;N Hahn;J Efstathiou;M Carducci
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS4590) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8185

A randomized phase III post-operative trial of platinum-based chemotherapy (P) vs. capecitabine (C) in patients (pts) with residual triple-negative breast (TNBC) cancer following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Authors
IA Mayer;F Zhao;C Arteaga;W Symmans;B Park;B Burnette;A Tevaarwerk;S Garcia;K Smith;E Mayer;W Sikov;E Rodler;L Wagner;A DeMichele;J Sparano;A Wolff;K Miller
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 605) (American Society of Clinical Oncology Annual Meeting 2021, LBA, oral session)
Year
2021
Research Committee(s)
Breast
Study Number(s)
CTSU/EA1131

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-Grade Neuroendocrine Neoplasm Cohort

Authors
S Patel;M Othus;YK Chae;J Strosberg;J Wang;B Konda;J Hayward;C McLeod;H Chen;E Sharon;E Mayerson;C Ryan;M Plets;CD Blanke;R Kurzrock
Journal / Conference
Cancer Sep 1;127(17):3194-3201; Apr 21. doi: 10.1002/cncr.33591. Online ahead of print
Year
2021
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID33882143
PMC
PMC8606104
Study Number(s)
S1609

Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry

Authors
M Graff;A Justice;K Young;E Marouli;X Zhang;R Fine;P Goodman;A Hsing;E Klein;M Neuhouser;L Sucheston;R Loos;M Ng;K North
Journal / Conference
American Journal of Human Genetics Apr 1;108(4):564-582. doi: 10.1016/j.ajhg.2021.02.011. Epub 2021 Mar 12.
Year
2021
Research Committee(s)
Prevention and Epidemiology
PMID
PMID33713608
PMC
PMC8059339
Study Number(s)
S0000

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

Authors
P Goodwin;R O'Dowling;M Ennis;B Chen;W Parulekar;L Shepherd;M Burnell;R Vander Meer;A Molckovsky;A Gurjal;K Gelmon;J Ligibel;D Hershman;I Mayer;T Whelan;T Hobday;P Rostogi;M Rabaglio-Poretti;J Lemieux;A Thompson;D Rea;V Stambolic
Journal / Conference
NPJ Breast Cancer Jun 8;7(1):74. doi: 10.1038/s41523-021-00275-z.
Year
2021
Research Committee(s)
Breast
PMID
PMID34103538
PMC
PMC8187713

Novel Clinical Trial Designs in Pursuit of Precision Oncology: Lung-MAP As a Model [Editorial]

Authors
J Riess;C Rolfo;D Gandara
Journal / Conference
Clinical Lung Cancer May;22(3):153-155. doi: 10.1016/j.cllc.2021.03.013.
Year
2021
Research Committee(s)
Lung
PMID
PMID33879399
Study Number(s)
S1400, S1400A, S1400B, S1400C, S1400D, S1400E, S1400G

Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial

Authors
C Steuer;O Jegede;S Dahlberg;H Wakelee;S Keller;W Tester;D Gandara;S Graziano;A Adjei;C Butts;S Ramalingam;J Schiller
Journal / Conference
Journal of Thoracic Oncology Jun;16(6):960-967. doi: 10.1016/j.jtho.2020.12.017. Epub 2021 Feb 1.
Year
2021
Research Committee(s)
Lung
PMID
PMID33539971
PMC
PMC8383783
Study Number(s)
CTSU/E1505

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Authors
M Wieduwilt;W Stock;A Advani;S Luger;R Larson;M Tallman;F Appelbaum;M-J Zhang;K Bo-Subait;H-L Wang;V Bhatt;B Dholaria;M Eapen;M Hamadani;O Jamy;T Prestidge;M Pulsipher;D Ritchie;D Rizzieri;A Sharma;P Barba;B Sandmaier;M de Lima;P Kebriaei;M Litzow;W Saber;D Weisdorf
Journal / Conference
Leukemia Jul;35(7):2076-2085
Year
2021
Research Committee(s)
Leukemia
PMID
PMID33785862
PMC
PMC8257494
Study Number(s)
C10403

Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)

Authors
J Sands;S Mandrekar;D Kozono;G Oxnard;S Hillman;D Wigle;R Govindan;J Carlisle;J Gray;J Salama;L Raez;A Ganti;N Foster;S Malik;J Bradley;K Kelly;S Ramalingam;T Stinchcombe
Journal / Conference
Immunotherapy Jun;13(9):727-734. doi: 10.2217/imt-2021-0019. Epub 2021 Apr 21
Year
2021
Research Committee(s)
Lung
PMID
PMID33878954
PMC
PMC8293026
Study Number(s)
CTSU/A081801